Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.6B | 2.9B | 1.9B | 1.7B |
Cost of revenue | 1.0B | 1.5B | 1.1B | 1.0B |
Gross profit | 593.7M | 1.4B | 771.7M | 697.9M |
Operating expense | ||||
Research & development | 22.4M | 46.7M | 21.9M | 20.9M |
Selling general and admin | 427.8M | 258.1M | 840.8M | 254.2M |
Other operating expenses | 14.1M | 29.0M | 17.4M | 19.1M |
Operating income | 153.8M | 428.6M | 222.9M | 150.1M |
Non operating interest income | ||||
Income | 3.3M | 6.2M | 2.3M | 2.6M |
Expense | 13.7M | 3.6M | 7.3M | 5.7M |
Other income expense | — | — | — | — |
Pretax income | 149.1M | 437.1M | 213.1M | 136.6M |
Tax provision | 35.6M | 76.4M | 56.3M | 23.9M |
Net income | 113.6M | 360.7M | 156.8M | 112.7M |
Basic EPS | 0.1 | — | — | — |
Diluted EPS | 0.1 | — | — | — |
Basic average shares | 754.0M | — | — | — |
Diluted average shares | 754.0M | — | — | — |
EBITDA | 156.5M | 434.1M | 237.4M | 160.2M |
Net income from continuing op. | — | — | — | — |
Minority interests | -23.1M | -100.0M | 1.1M | -1.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |